Clinical Trial Update: An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy, safety and tolerability of flexibly dosed paliperidone extended-release in adults with schizophrenia; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-02-06